Skip to main content
ITRI logo

ITRI · Itron, Inc.

Track ITRI — free
$86.60 +0.26 (+0.30%)
Market Cap
$3.93B
Shares
43.79M
Volume · Sep 30 777K Avg daily vol (3M) 739.33K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$86.34 Open$87.83 Day$86.30–89.00 52W close$78.02–138.18 Avg vol 30d542K Short int6.1M · 14.0% float · 13.5d Short vol80% Last earningsJul 28, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 28

Up next

Next earnings call
Oct 27, 2026 Est · unconfirmed · in 4 wks
filed Jul 28, 2026
call held Jul 28, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-29.6%
Trailing year
Short interest
14.0%
Latest settlement · 13.5 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 28, 2026
Q2 FY26

TL;DR. Itron delivered record 41.4% adjusted gross margin and raised its full-year non-GAAP EPS outlook to $6.30-$6.50 (up 7% at the midpoint), despite a 7% revenue decline driven by project deployment timing in Networked Solutions. Annual recurring revenue grew 21% year-over-year to $417 million, and the new Resiliency Solutions segment contributed $16 million with 75% adjusted gross margin.

Bullish
  • + Raised full-year non-GAAP EPS outlook to $6.30-$6.50, up 7% at midpoint from February
  • + Annual recurring revenue grew 21% year-over-year to $417 million
  • + New Resiliency Solutions segment delivered $16 million revenue with 75% adjusted gross margin
  • + Adjusted EBITDA of $97 million, up 8% year-over-year
Bearish
  • − Q2 revenue declined 7% year-over-year to $563 million
  • − Networked Solutions revenue fell 17% on project deployment timing
  • − GAAP diluted EPS fell to $1.19, down $0.28 from $1.47 prior year
  • − Free cash flow declined to $81 million from $91 million year-ago
  • − Full-year non-GAAP EPS projected below 2025 on as-reported basis

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −6%
below
Price vs 50-day avg −10%
below
RSI (14) 30
oversold
MACD trend Negative
52-week position 14%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −9%
trailing
6-month return −9%
trailing
YTD return −7%
this year
Relative strength −21%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $96 › 200d $92 — 50d above 200d
Institutional flow Distributing
-5% holders QoQ · +57 funds added
Insider flow Distributing
Net -$895.4K over 90 days · 100% sells
Short interest Falling
13.96% of float · ▼ -1.9% MoM · 13.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
418 holders — mid 3-yr range
Squeeze score 73
high risk · 0–100
Fundamentals
Excellent
Revenue growth −3%
Y/Y
Gross margin 38%
expanding
EPS growth +25%
Y/Y
Free cash flow $383.1M
Valuation P/E 15
below peers
Buyback $200.0M
authorized
Balance sheet $227.9M
net debt
Quant / Vol
risk profile
Very High
Volatility 48%
annualized · 1-yr
Max drawdown −44%
past year
ATR 3.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 7 of last 8
Latest guidance · from the Earnings Call filed Jul 28, 2026
third quarter
Q3 revenue $590M – $600M
prior qtr $562.9M midpoint +5.7% QoQ
full year
Full year revenue $2.37B – $2.41B
prior FY $2.37B midpoint +1.0% Y/Y
Full-year non-GAAP earnings per share Non-GAAP $6.30 – $6.50
Guided vs delivered · last 8 settled
Revenue third quarter 2024
guided $590M – $600M
$615.46M Beat +3.4%
Revenue full year 2024
guided $2.39B – $2.42B
$2.44B Beat +1.7%
Revenue second quarter of 2024
guided $595M – $605M
$609.07M Beat +1.5%
Revenue First quarter 2024
guided $575M – $585M
$603.44M Beat +4.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−6% Bearish
Price vs 50-day avg
−10% Bearish
RSI (14)
30 Neutral
MACD trend
Negative Bearish
52-week position
14% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $96 › 200d $92 — 50d above 200d
Institutional flow Distributing
-5% holders QoQ · +57 funds added
Insider flow Distributing
Net -$895.4K over 90 days · 100% sells
Short interest Falling
13.96% of float · ▼ -1.9% MoM · 13.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
418 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $78 Now $86 · 14% Range high $138
vs 200-day avg -6% vs 50-day avg -10%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $96.84M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP GAAP net income attributable to Itron, Inc. 53.27M
-6.25M Interest income
+5.77M Interest expense
+26.73M Income tax provision
+18.63M Depreciation and amortization
+233K Restructuring
+0K Loss on sale of business
+455K Strategic initiative
+1.25M Acquisition and integration
-3.25M Gain on sale of equity method investment
= Adjusted EBITDA 96.84M
Adjusted gross profit non-GAAP 233.21M Three months ended June 30, 2026 filing —
Adjusted segment operating income non-GAAP 168.5M Three Months Ended June 30, 2026 filing —
Annual recurring revenue 417M Three Months Ended June 30, 2026 filing —
Free Cash Flow non-GAAP 81.49M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net cash provided by operating activities 88.09M
-6.61M Acquisitions of property, plant, and equipment
= Free Cash Flow 81.49M
Non-GAAP diluted EPS non-GAAP $1.59 the three months ended June 30, 2026 filing —
Non-GAAP net income attributable to Itron, Inc. non-GAAP 70.73M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP GAAP net income attributable to Itron, Inc. 53.27M
+11.05M Amortization of intangible assets
+1.93M Amortization of debt placement fees
+233K Restructuring
+0K Loss on sale of business
+455K Strategic initiative
-3.25M Gain on sale of equity method investment
+1.25M Acquisition and integration
+5.79M Income tax effect of non-GAAP adjustments
= Non-GAAP net income attributable to Itron, Inc. 70.73M
Non-GAAP operating expenses non-GAAP $144.16M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP GAAP operating expenses 154.57M
-8.48M Amortization of intangible assets (1)
-233K Restructuring
+0K Loss on sale of business
-455K Strategic initiative
-1.25M Acquisition and integration
= Non-GAAP operating expenses 144.16M
Non-GAAP operating income non-GAAP $89.05M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP GAAP operating income 76.07M
+11.05M Amortization of intangible assets
+233K Restructuring
+0K Loss on sale of business
+455K Strategic initiative
+1.25M Acquisition and integration
= Non-GAAP operating income 89.05M
Total backlog 4.4B the three months ended June 30, 2026 filing —
Twelve-month backlog 1.7B the three months ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Scientific & Technical Instruments — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ITRI
Itron, Inc.
this stock
$3.93B -7.0% -3.0% 15.0 14.0%
KEYS
Keysight Technologies, Inc.
$61.65B +79.2% +8.0% 49.6 1.4%
GRMN
Garmin Ltd
$56.73B +41.4% +15.1% 32.8 1.6%
COHR
Coherent Corp.
$55.49B +55.9% +19.2% 68.8 5.2%
TDY
Teledyne Technologies Inc
$28.47B +18.8% -4.6% 29.7 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
418
% held
121.3%
Net QoQ
+879.7K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
423
View
Short & Settlement
Short Interest Falling
Shares short
6.1M
Days to cover
13.5d
Change
-117.6K sh
View
Short Volume
Short vol %
80%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
4
Value
$388
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
48.3%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$895.4K
Buyers / Sellers
0 / 8
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$2.4B
Net income (FY)
$301.1M
EPS diluted
$6.50
View
Buybacks
Authorized
$200.0M
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Aug 11, 2026
This year
12
View
Proposed Sales
Value
$994.0K
Shares
10.2K
Filed
Sep 3, 2026
View
Earnings & Events
Earnings Calls
Last call
Aug 11, 2026
View

Performance

5D 20D 120D MTD YTD
ITRI -5.5% -9.2% -9.2% -11.0% -7.0%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -4.8% -9.3% -21.4% -10.4% -18.9%

Capital returns

Buyback program · as of May 6, 2026
Authorized
$200.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 780571 CUSIP 465741106 13F (30d) 12 filings 8 filers Visit website Investor relations